Radio (ROIA) Appoints Samuel Rogers to VP National Sales

WASHINGTON, Jan. 28, 2013 /PRNewswire/ — Radio One, Inc. (Nasdaq: ROIAK and ROIA) announced today that Samuel Rogers has been named Vice President of National Sales.

Samuel Rogers has over 30 years of experience managing sales, marketing, programming, and operations in the broadcasting industry.  He was with CBS Radio for 23 years as he rose through the ranks from Local Sales Manager to Senior Vice President and then on to Market Manager.  He was most recently with Cumulus Radio as both a Market Manager and Vice President of Political and Platform Sales.   Mr. Rogers will be assuming this newly created position on January 30 and will be reporting to Christopher Wegmann. As Vice President of National Sales, Mr. Rogers will be responsible for maintaining and expanding the opportunities for advertisers to reach a national audience through Radio One’s national footprint.

“I am extremely excited to be part of Radio One’s team after having competed against them for most of my career.  I really am looking forward to working with a great group of professionals and outstanding properties.  By coordinating our national sales efforts, we will be able to offer advertisers access to the substantial buying power of the African-American market coupled with the speed and efficiency advertisers and their agencies demand in today’s environment.  This is a great opportunity!” said Mr. Rogers.

Christopher Wegmann, Regional Vice President stated, “We are very pleased that Sam is now on our team.  His lengthy proven track record in the DC market and on a national level makes him a great fit for this new position here at Radio One.  Under his leadership we will see more coordinated efforts from all of our Radio markets and digital platforms to move us to the next level with our national clients.”

ABOUT RADIO ONE, INC.

Radio One, Inc., together with its subsidiaries (http://www.radio-one.com/), is a diversified media company that primarily targets African-American and urban consumers. The Company is one of the nation’s largest radio broadcasting companies, currently owning and/or operating 55 broadcast stations located in 16 urban markets in the United States.  Through its controlling interest in Reach Media, Inc. (http://www.blackamericaweb.com/), the Company also operates syndicated programming including the Tom Joyner Morning Show, the Russ Parr Morning Show, the Yolanda Adams Morning Show, the Rickey Smiley Morning Show, CoCo Brother Live, CoCo Brother’s “Spirit” program, Bishop T.D. Jakes’ “Empowering Moments”, the Reverend Al Sharpton Show, and the Warren Ballentine Show. Beyond its core radio broadcasting franchise, Radio One owns Interactive One (http://www.interactiveone.com/), an online platform serving the African-American community through social content, news, information, and entertainment.   Interactive One operates a number of branded sites, including News One, UrbanDaily, HelloBeautiful and social networking websites, including BlackPlanet, MiGente, and Asian Avenue. In addition, the Company owns a controlling interest in TV One, LLC (http://www.tvoneonline.com/), a cable/satellite network programming primarily to African-Americans.

TeleCommunication Systems (TSYS) Completes Phase 1 Next Gen 9-1-1 Network

ANNAPOLIS, Md., Jan. 25, 2013 /PRNewswire/ — TeleCommunication Systems, Inc. (TCS) (NASDAQ: TSYS), a world leader in highly reliable and secure mobile communication technology, today announced the phase one deployment of the Next Generation 9-1-1 services network for the State of Iowa, the first state in the nation to complete a statewide deployment of a National Emergency Number Association (NENA) i3-compliant Next Generation 9-1-1 (NG 9-1-1) system. This emergency services network improves the public’s access to 9-1-1 through the use of leading-edge technology provided by TCS and sets the stage for people in Iowa to eventually transmit text, images and video to public safety answering points (PSAPs).

News Facts:

• All 119 PSAPs in the state are now interconnected to the NG9-1-1 system in accordance with the NENA i3 specifications, thus creating the largest contiguous NG9-1-1 network in the nation.
• Every wireless telecommunications operator in Iowa now sends its wireless 9-1-1 traffic through the Iowa NG9-1-1 system, which then processes and routes the information to the appropriate PSAP.
• Iowa’s emergency services network is now able to receive and process requests from legacy and new technologies and boasts full compliance with NENA i3 specifications.
• TCS’ NG9-1-1 solution updates traditional 9-1-1 infrastructure to improve public emergency communication services by enabling the public to transmit text, images, video and data to the 9-1-1 Public Safety Answering Points (PSAPs).
• NG9-1-1 solutions support IP-based technologies to enable sharing of information across jurisdictions, interoperability with distant agencies and enhanced incoming call information.
• This deployment is phase one of a five-year contract with the State of Iowa Homeland Security Emergency Management Division (HSEMD) a five-year contract for NG 9-1-1 systems and services.

TCS’ NG9-1-1 solution offers options to public safety providers that increase control over the system, bypass costly legacy architecture and deploy the solution as systems, services or a mix of the two within any existing IP network. For more information on TCS’ NG9-1-1 solutions, visit http://www.telecomsys.com/NG9-1-1.

Supporting Quotes:

Barbara Vos, E9-1-1 program manager, Iowa HSEMD, said:
“A great many Iowans use communication devices that offer text, video and picture messaging capabilities; and we must be able to utilize this technology as a tool to increase the safety of our citizens. We have an average of 53,000 emergency calls each day in Iowa. With TCS’ NG9-1-1 solutions, our PSAPs are now able to receive detailed information quickly and accurately. TCS’ flexibility enabled us to customize a solution in order to meet our specific needs; and now our PSAPs are better equipped to respond to emergencies, thus improving public safety.”

Chris Nabinger, senior vice president and general manager, Safety & Security Group, TCS, said:
“TCS is dedicated to improving public safety and emergency response by accelerating the evolution of wireless communication technologies. Completing the first statewide deployment of NG 9-1-1 is a major accomplishment that we are proud to have led. The state of Iowa is driving the nation’s transition of emergency communication from legacy architecture to an IP-based infrastructure, enabling the public to leverage the wireless technologies used daily to contact 9-1-1 quickly and reliably.”

About TeleCommunication Systems, Inc.

TeleCommunication Systems, Inc. (TCS) (NASDAQ: TSYS) is a world leader in highly reliable and secure mobile communication technology. TCS infrastructure forms the foundation for market leading solutions in E9-1-1, text messaging, commercial location and deployable wireless communications. TCS is at the forefront of new mobile cloud computing services providing wireless applications for navigation, hyper-local search, asset tracking, social applications and telematics. Millions of consumers around the world use TCS wireless apps as a fundamental part of their daily lives. Government agencies utilize TCS’ cyber security expertise, professional services, and highly secure deployable satellite solutions for mission-critical communications. Headquartered in Annapolis, MD, TCS maintains technical, service and sales offices around the world. To learn more about emerging and innovative wireless technologies, visit www.telecomsys.com.

Except for the historical information contained herein, this news release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties and are based upon TeleCommunication Systems’ current expectations and assumptions that if incorrect would cause actual results to differ materially from those anticipated. Risks include those detailed from time to time in the Company’s SEC reports, including the report on Form 10-K for the year ended December 31, 2011 and on Form 10-Q for the quarter ended September 30, 2012.

Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information in this press release, whether as a result of new information, future events or circumstances, or otherwise.

(Logo: http://photos.prnewswire.com/prnh/20120503/PH99996LOGO)

WebMediaBrands (WEBM) Terry Wohlers to Keynote Inside 3D Printing Conference

WebMediaBrands Inc.(Nasdaq: WEBM) today announced that renowned additive manufacturing and 3D printing consultant Terry Wohlers will be the keynote speaker at the Javits Convention Center, April 22–23, 2013.

“Terry Wohlers has long been recognized as having the best grasp of developments in the future of 3D printing,” stated Alan Meckler, Chairman and CEO of WebMediaBrands. “Having Terry Wohlers and program chair Hod Lipson as part of the conference ensures that attendees will be presented a comprehensive understanding of the future business opportunities for 3D printing.”

Terry Wohlers is principal consultant and president of Wohlers Associates, Inc., an independent consulting firm providing consulting assistance to more than 190 organizations in 23 countries. He has authored nearly 400 books, articles, and technical papers and was selected the No. 1 most influential person in rapid product development and additive manufacturing.

Dr. Hod Lipson is an associate professor and the director of the Creative Machines Lab at Cornell University. He co-authored the book, Fabricated: The New World of 3D Printing, which will be published February 4, 2013 by John Wiley & Sons.

For event information and registration, please visit: http://inside3dprinting.com

For exhibiting and sponsorship information, please contact Marilyn Reed at 3dprinting.sponsors@mediabistro.com or 518-793-8167.

About WebMediaBrands Inc.

WebMediaBrands Inc. (Nasdaq: WEBM) (http://www.webmediabrands.com) is a leading Internet media company that provides content, education, and career services to social media, traditional media, and creative professionals through a portfolio of vertical online properties, communities, and trade shows. The Company’s online business includes: (i) mediabistro.com, a leading blog network providing content, education, community, and career resources (including the industry’s leading online job board) about major media industry verticals including new media, social media, Facebook, TV news, advertising, public relations, publishing, design, and mobile; (ii) InsideNetwork.com, a leading network of online properties providing original market research, data services, news, and job listings on the Facebook platform, on social gaming, and on mobile applications ecosystems; and (iii) SemanticWeb.com, a leading blog providing content, education, community resources and career resources on the commercialization and application of Semantic Technologies, Linked Data, and Big Data. The Company’s online business also includes community, membership and e-commerce offerings including a freelance listing service, a marketplace for designing and purchasing logos (stocklogos.com) and premium membership services. The Company’s trade show and educational offerings include conferences, online and in-person courses, and video subscription libraries on topics covered by the Company’s online business.

All current WebMediaBrands press releases can be found online at http://www.webmediabrands.com/corporate/press.html

UniPixel (UNXL) Sets Fourth Quarter and Full Year 2012 Conference Call

THE WOODLANDS, TX — (Marketwire) — 01/25/13 — UniPixel, Inc. (NASDAQ: UNXL), a provider of Performance Engineered Films™ to the touch screen, flexible printed electronics, and lighting and display markets, will hold a conference call on Tuesday, February 26, 2013 at 4:30 p.m. Eastern time to discuss the fourth quarter and full year ended December 31, 2012. Financial results will be issued in a press release prior to the call.

UniPixel President and CEO Reed Killion and CFO Jeff Tomz will host the presentation, followed by a question and answer period.

Date: Tuesday, February 26, 2013
Time: 4:30 p.m. Eastern time (3:30 p.m. Central time)
Dial-In Number: 1-877-941-4774
International: 1-480-629-9760
Conference ID#: 4593770
Webcast: http://public.viavid.com/index.php?id=103296

The conference call will be broadcast live and available for replay via the Investors section of the company’s website at www.unipixel.com.

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.

A replay of the call will be available after 7:30 p.m. Eastern time on the same day through March 26, 2013.

Toll-free replay number: 1-877-870-5176
International replay number: 1-858-384-5517
Replay pin number: 4593770

About UniPixel
Headquartered in The Woodlands, Texas, UniPixel, Inc. (NASDAQ: UNXL) delivers Performance Engineered Films to the Lighting, Display and Flexible Electronics markets. UniPixel’s high-volume roll-to-roll or continuous flow manufacturing process offers high-fidelity replication of advanced micro-optic structures and surface characteristics over large areas. A key focus for UniPixel is developing electronic conductive films for use in electronic sensors for consumer and industrial applications. The company’s newly developed UniBoss™ roll-to-roll electronics manufacturing process prints conductive elements on thin film with trace widths down to ~ 5um. The company is marketing its films for touch panel sensor, cover glass replacement, protective cover film, antenna and custom circuitry applications under the UniPixel label, and potentially under private label or Original Equipment Manufacturers (OEM) brands. UniPixel’s brands include Clearly Superior™, Diamond Guard™ and others. For further information, visit www.unipixel.com.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Company Contact:
Jeff Tomz
CFO
UniPixel, Inc.
Tel 281-825-4500

Investor Relations Contact:
Scott Liolios or Ron Both
Liolios Group, Inc.
Tel 949-574-3860
Email Contact

Severn Bancorp (SVBI) Announces Fourth Quarter Earnings

UQM Technologies (UQM) to Hold Conference Call

UQM TECHNOLOGIES, INC. (NYSE MKT:UQM), a developer of alternative energy technologies, will hold a conference call with members of the investment community on Thursday, January 31, 2013, at 4:30 p.m. Eastern Time. To participate in the call dial 1-877-941-6009 approximately 10 minutes before the conference is scheduled to begin and provide conference ID code “4591697” to access the call. International callers should dial 1-480-629-9819.

Eric R. Ridenour, UQM Technologies’ President and Chief Executive Officer and Donald A. French, Treasurer and Chief Financial Officer, will be reviewing the Company’s operating results for the quarter and nine months ended December 31, 2012.

For anyone who is unable to participate in the conference, access to a recording will be available for 7 days following the call. Dial 1-800-406-7325 and enter replay access code 4591697# to access the playback. International callers should dial +1-303-590-3030. Please allow one hour from the time of the conference call for initial setup before access.

UQM Technologies is a developer and manufacturer of power-dense, high-efficiency electric motors, generators and power electronic controllers for the automotive, commercial truck, bus, marine and military markets. A major emphasis for UQM is developing propulsion systems for electric, hybrid electric, plug-in hybrid electric and fuel cell electric vehicles. UQM is located in Longmont, Colorado.

Please visit www.uqm.com for more information.

Giga-tronics (GIGA) Adopts Shareholder Rights Plan

SAN RAMON, Calif., Jan. 24, 2013 (GLOBE NEWSWIRE) — Giga-tronics Incorporated (Nasdaq:GIGA) today announced that its Board of Directors has adopted a Shareholder Rights Plan designed to assure that all Giga-tronics Shareholders would receive fair treatment in any takeover of the Company. The Plan provides for the distribution of one Right for each share of common stock outstanding on the record date of February 4, 2013.

In making the announcement, Garrett A. Garrettson, the Chairman of Giga-tronics, stated: “The Rights are designed to enable the Board of Directors to act effectively on behalf of Shareholders in response to any takeover bid. The Plan is not intended to prevent or discourage an offer for the Company that is commensurate with its value and is presented in a manner permitting full review and negotiation.” Mr. Garrettson also noted that, “the Company has not received any unsolicited acquisition proposal at this time.”

The Rights Plan provides that in the event any person becomes the beneficial owner of 20% or more of the outstanding common shares (with specified exceptions for certain affiliated shareholders whose aggregate beneficial holdings now exceed 20%, provided their holdings do not increase materially), each Right (other than a Right held by the 20% Shareholder) will be exercisable, on and after the close of business on the tenth business day following such event, for the purchase a number of Giga-tronics common shares (or equivalent securities) equal to the exercise price (initially $15.00) divided by 50% of the then current fair market value of the common stock. The Plan further provides that if, on or after the occurrence of such event, the Company is merged into any other corporation or 50% or more of the Company’s assets or earning power are sold, each Right (other than a Right held by the 20% Shareholder) will be exercisable to purchase a similar number of securities of the acquiring corporation.

The Rights expire on February 4, 2018 (unless previously triggered), and are subject to redemption by the Board of Directors at $.001 per Right at any time prior to the first date upon which they become exercisable to purchase common shares.

Giga-tronics will provide Shareholders with further details of the Rights Plan in a letter to be mailed in the next several weeks.

Giga-tronics is a publicly held company, traded on the NASDAQ Capital Market under the symbol “GIGA”. Giga-tronics produces instruments, subsystems and sophisticated microwave components that have broad applications in defense electronics, aeronautics and wireless telecommunications.

The Giga-tronics Incorporated logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6087

CONTACT: Frank Romejko
         Vice President of Finance / Interim Chief Financial Officer
         (925) 302-1014

Biodel (BIOD) Positive Results Clinical Study Ultra-Rapid-Acting Insulin Analog Candidates

• BIOD-238 and BIOD-250 demonstrate a pharmacokinetic profile superior to Humalog^® with ultra-rapid absorption and rapid declines from peak concentration
• BIOD-250 demonstrates injection site toleration comparable to Humalog^®

DANBURY, Conn., Jan. 24, 2013 (GLOBE NEWSWIRE) — Biodel Inc. (Nasdaq:BIOD) today announced positive top-line results from a Phase 1 clinical trial of two ultra-rapid-acting insulin analog-based formulations, BIOD-238 and BIOD-250, conducted to evaluate the pharmacokinetic and injection site toleration profiles relative to Humalog^®, a rapid-acting insulin analog. BIOD-238 and BIOD-250 are combinations of Biodel’s proprietary excipients with the marketed formulation of Humalog^®.

The single-center, randomized, double-blind, three-period crossover trial in 12 patients with Type 1 diabetes was conducted in Australia. Each study drug was administered subcutaneously on separate days. Pharmacokinetic measurements were made using an assay to quantify the active ingredients in the study drugs and Humalog^®. The clinical trial was powered to measure differences in time to half-maximal insulin concentrations. The hypothesis tested in this study was than Biodel’s formulations of Humalog^® would have ultra-rapid absorption profiles with comparable declines from peak concentration and comparable injection site tolerability profiles relative to Humalog^®. Two approaches were taken to mitigate injection site discomfort—reducing disodium EDTA concentrations (BIOD-238) and addition of magnesium sulfate (BIOD-250), which was observed to improve toleration in a previous study.

The pharmacokinetic profiles of BIOD-238 and BIOD-250 proved to be consistent with our target product profile for analog-based ultra-rapid-acting insulin. Absorption rates of BIOD-238 and BIOD-250 were significantly more rapid than that of Humalog^®, as indicated by 35-45% reductions in mean times to half maximal insulin concentrations (p<0.001 for BIOD-238 and p=0.001 for BIOD-250 vs. Humalog^®) and time to maximal insulin concentrations (p=0.013 for BIOD-238 and p=0.025 for BIOD-250 vs. Humalog^®). Furthermore, the total amount of insulin absorbed over the first 30 minutes following injection of BIOD-238 and BIOD-250 was approximately double that seen for Humalog^® (p<0.001 for BIOD-238 and p=0.002 for BIOD-250 vs. Humalog^®). The decline from peak concentration, as indicated by time to half maximal concentration after the peak, was significantly shorter for both BIOD-238 and BIOD-250 compared to Humalog^® (p=0.009 for BIOD-238 and p=0.016 for BIOD-250 vs. Humalog^®).

Local injection site discomfort was measured with a 100 mm visual analog scale (VAS) and patient questionnaires. 100 mm is defined as the worst possible discomfort and 0 mm is defined a having no discomfort. In the trial, the VAS score was numerically lower, but not significantly different for BIOD-250 compared to Humalog^® (mean VAS scores of 2.7 mm and 8.2 mm for BIOD-238 and Humalog^®, respectively; p=NS). The VAS score for BIOD-238 was significantly higher than that associated with Humalog^® (mean VAS score of 24.2 mm, p=0.029 vs. Humalog^®).

Dr. Alan Krasner, Biodel’s chief medical officer, stated: “This study corroborates pharmacokinetic observations made previously in the diabetic swine model, namely that Biodel’s excipients accelerate the absorption of an insulin analog without prolonging the decline from peak concentration. This profile is different than that of the recombinant human insulin-based formulation BIOD-123, which is associated with a modestly longer decline from peak concentration compared to Humalog^®. The optimal decline from peak concentration for a prandial insulin is unknown and what is desirable may vary by patient.”

Errol De Souza, Biodel’s president and chief executive officer, stated: “The findings from these studies are very encouraging. Having established the proof of principle in man, we are now focused on replicating the pharmacokinetic and tolerability profiles of BIOD-250 in formulations utilizing lispro, the active pharmaceutical ingredient in Humalog^®, and in achieving commercial stability. We are pleased to have confirmed that we have a tolerability profile equivalent to currently marketed products, as previously seen in our Phase 1 trial of the recombinant human insulin-based ultra-rapid-acting candidate BIOD-123. BIOD-123 is now in a Phase 2 clinical trial scheduled to generate top line data in the third calendar quarter of 2013.”

About Biodel Inc.

Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles.

Safe-Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements about future activities related to the clinical development plans for the company’s drug candidates, including the potential timing, design and outcomes of clinical trials; and the company’s ability to develop and commercialize product candidates. Forward-looking statements represent our management’s judgment regarding future events. All statements, other than statements of historical facts, including statements regarding our strategy, future operations, future clinical trial results, future financial position, future revenues, projected costs, prospects, plans and objectives of management are forward-looking statements. The words “anticipates,” “believes,” “could,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The company’s forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, the success of our product candidates, particularly our proprietary formulations of injectable insulin that are designed to be absorbed more rapidly than the “rapid-acting” mealtime insulin analogs presently used to treat patients with Type 1 and Type 2 diabetes and our liquid glucagon formulation that is intended to treat patients experiencing severe hypoglycemia; our ability to successfully complete a Phase 2 clinical trial of a proprietary insulin formulation in a timely manner, and the outcome of that trial; our ability to conduct pivotal clinical trials, other tests or analyses required by the U.S. Food and Drug Administration, or FDA, to secure approval to commercialize a proprietary formulation of injectable insulin or a liquid formulation of glucagon; the success of our formulation development work with insulin analog-based formulations of a proprietary injectable insulin and a liquid formulation of glucagon; our ability to secure approval from the FDA for our product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; the progress, timing or success of our research, development and clinical programs, including any resulting data analyses; our ability to develop and commercialize a proprietary formulation of injectable insulin that may be associated with less injection site discomfort than Linjeta™ (formerly referred to as VIAject^®), which is the subject of a complete response letter we received from the FDA; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of any such collaborations into which we enter, or our ability to commercialize our product candidates ourselves; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; the degree of clinical utility of our product candidates; the ability of our major suppliers to produce our products in our final dosage form; our commercialization, marketing and manufacturing capabilities and strategies; our ability to accurately estimate anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our most recent report on Form 10-K for the year ended September 30, 2012. The company disclaims any obligation to update any forward-looking statements as a result of events occurring after the date of this press release.

Revolution (RVLT) Announces Seesmart LED Lighting Order

CHARLOTTE, N.C., Jan. 24, 2013 /PRNewswire/ — Revolution Lighting Technologies, Inc. (NASDAQ: RVLT), a leader in advanced LED lighting technology, announces the receipt of a $5 million order for LED lighting products with a total potential value of $10 million. The energy-efficient LED products will be manufactured by U.S.-based Seesmart, Inc., a wholly owned subsidiary of Revolution Lighting Technologies, and will be installed in retail stores, office complexes, warehouses and storage facilities. The majority of the order will be installed within the first quarter of 2013. Revolution Lighting Technologies expects to receive a second order totaling $5 million immediately thereafter.

“This initial order further validates our belief that there is an acceleration of the LED lighting market taking place in the U.S. and abroad. We continue to see a significant increase in our addressable market and believe this will continue for the remainder of 2013 and beyond,” said Robert V. LaPenta, Chairman of Revolution Lighting Technologies, Inc.

“We are anticipating tremendous growth in 2013 as the millions of dollars of quotes in our pipeline begin to convert to sales,” said Ken Ames, Director of Sales for Seesmart, Inc. “We have worked diligently in creating a solid network of 50 exclusive distributors and 300 representatives to educate the end-user about LED technology and its benefits. Seesmart is poised for rapid growth this year while continuing to bring high quality, value engineered products into the marketplace with key technology leaders.”

For more information, please visit the Revolution Lighting Technologies, Inc. web site at www.rvlti.com.

Certain of the above statements contained in this press release are forward-looking statements that involve a number of risks and uncertainties, including the satisfaction of closing conditions prior to the consummation of the acquisition of Seesmart and the anticipated benefits of such acquisition. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Reference is made to Revolution Lighting’s filings under the Securities Exchange Act for additional factors that could cause actual results to differ materially. Revolution Lighting Technologies, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those indicated in the forward-looking statements as a result of various factors. Readers are cautioned not to place undue reliance on these forward-looking statements.

Inuvo (INUV) Preliminary Unaudited 2012 Revenue Increased 49% to $53.3 Million

NEW YORK, NY — (Marketwire) — 01/23/13 — Inuvo, Inc. (NYSE MKT: INUV) (the “Company” or “Inuvo”), an Internet company that develops and markets browser based consumer applications and manages networks of websites today announced that the Company’s preliminary unaudited revenue for fiscal year 2012 was $53.3 million, up from $35.8 million in fiscal year 2011. Preliminary unaudited revenue for the fourth quarter of 2012 was $16.2 million, a nearly 5% increase over the $15.5 million in revenue reported in the third quarter of 2012.

“Product launches and a key acquisition fueled Inuvo’s growth in revenue throughout 2012. We head into 2013 with a solid foundation,” stated Richard Howe, Chief Executive Officer of Inuvo. “We will continue executing on plans put in place in 2012 and be persistent in our efforts to reduce our expenses.”

The Company does not anticipate continuing to report preliminary unaudited revenue and will provide additional financial information when full-year 2012 financial results are available. Preliminary unaudited revenue includes financial results from the acquisition of Vertro from March 2012 forward, prior years do not include Vertro financial results.

About Inuvo, Inc.

Inuvo®, Inc. (NYSE MKT: INUV), an Internet Company that develops and markets browser based consumer applications and manages networks of websites today. To learn more about Inuvo, please visit www.inuvo.com.

Forward-looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Words or expressions such as “anticipate,” “plan,” “will,” “intend,” “believe” or “expect'” or variations of such words and similar expressions are intended to identify such forward-looking statements. Without limiting the generality of the foregoing, forward-looking statements contained in this press release specifically include the expectations of the Company’s preliminary unaudited revenue for full year 2012 and Q4 2012.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including, without limitation, statements made with respect to expectations with respect to: the strategy, markets, synergies, costs, efficiencies, and other anticipated financial impacts of the proposed transaction; the combined company’s plans, objectives, expectations, intentions with respect to future operations, fluctuations in demand; changes to economic growth in the U.S. economy; and government policies and regulations, including, but not limited to those affecting the Internet. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of Inuvo and are difficult to predict. Inuvo undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Additional key risks are described in the filings made by Inuvo with the U.S. Securities and Exchange Commission, including the Form 10-K for the year ended December 31, 2011 and most recent Form 10-Q.

Contact:

Alliance Advisors, LLC
Alan Sheinwald
914-669-0222
President
Email Contact

Inuvo, Inc.
Wally Ruiz
212-231-2000 Ext. 160
Chief Financial Officer
Email Contact

Saratoga Resources (SARA) Provides Update on Drilling Activities

Saratoga Resources, Inc. (NYSE MKT: SARA; the “Company” or “Saratoga”) today provided an update on recent drilling activities, including the results of the previously announced SL 195 QQ-209 “Buddy” development well and results of recompletion operations on the previously announced MP-47 SL 195 QQ-24 “Roux” well.

The Buddy development well in Grand Bay Field was drilled to a total depth of 6,820 feet MD/TVD and was successfully completed in the 3A sand. Flow testing of the Buddy well demonstrated an IP (initial production) test rate of 208 net barrels of oil equivalent per day (Boepd). Flowing tubing pressure was 580 pounds per square inch on a 19/64” choke.

The Roux well underwent a successful gravel pack recompletion in the 29M sand, while preparing the shallower 20 sand as a future non-gravel pack completion. Flow testing of the Roux well demonstrated an IP test rate of 154 net Boepd. Flowing tubing pressure was 990 pounds per square inch on a 18/64” choke.

Saratoga also announced that it has commenced drilling operations on the MP-47 SL 195 QQ-25 “Roux Toux” development well as a directional well to a projected total depth of 8,553’ MD/8,000’ TVD at the northern edge of the Grand Bay Field. The well is targeting the 10 through 17 sands. Drilling operations on the Roux Toux well are expected to be completed by early February.

Thomas F. Cooke, Chairman and CEO, stated, “We are pleased to announce successful operations on the Buddy and Roux wells. Not only did we add to our oil production, we came in substantially ahead of schedule and under budget. Our cost savings from these operations allowed us to move the Roux Toux well forward in our drilling schedule and minimize the time and cost associated with the mobilization of the Parker 50 drilling rig.”

About Saratoga Resources

Saratoga Resources is an independent exploration and production company with offices in Houston, Texas and Covington, Louisiana. Principal holdings cover 32,119 gross/net acres, mostly held-by-production (all depths), currently located in the transitional coastline and protected in-bay environment on parish and state leases of south Louisiana. Most of the company’s large drilling inventory has multiple pay objectives that range from as shallow as 1,000 feet to the ultra-deep prospects below 20,000 feet in water depths of less than 10 feet. For more information, go to Saratoga’s website at www.saratogaresources.com and sign up for regular updates by clicking on the Updates button.

Forward-Looking Statements

This press release includes certain estimates and other forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Words such as “expects”, “anticipates”, “intends”, “plans”, “believes”, “assumes”, “seeks”, “estimates”, “should”, and variations of these words and similar expressions, are intended to identify these forward-looking statements. While we believe these statements are accurate, forward-looking statements are inherently uncertain and we cannot assure you that these expectations will occur and our actual results may be significantly different. These statements by the Company and its management are based on estimates, projections, beliefs and assumptions of management and are not guarantees of future performance. Important factors that could cause actual results to differ from those in the forward-looking statements include the factors described in the “Risk Factors” section of the Company’s filings with the Securities and Exchange Commission. The Company disclaims any obligation to update or revise any forward-looking statement based on the occurrence of future events, the receipt of new information, or otherwise.

EntreMed (ENMD) Initiates Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma

ROCKVILLE, Md., Jan. 23, 2013 /PRNewswire/ — EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company, announced today the initiation of a single-center Phase 2 study entitled “A Phase 2 Study of Oral ENMD-2076 Administered to Patients with Advanced/Metastatic Soft Tissue Sarcoma” at Princess Margaret Hospital where the study is led by Malcolm Moore, MD and Albiruni R.A. Razak, MD.  The study is sponsored by Princess Margaret Cancer Centre. More information about the clinical trial can be found at www.clinicaltrials.gov.

(Logo:  http://photos.prnewswire.com/prnh/20010620/ENMDLOGO)

Albiruni R.A. Razak, MD, commented on the study, “Soft tissue sarcomas (STS) are diverse mesenchymal tumors that commonly affect patients in the prime of life.  The prognosis for patients with advanced/metastatic sarcoma remains poor and there are limited options for their treatment.  The median disease progression-free survival (PFS) for those patients is less than two months without treatment or less than five months with treatments currently available. This is certainly an area of unmet medical need.  The primary objective of this Phase 2 study is to evaluate the safety and efficacy of ENMD-2076 in advanced/metastatic STS patients with the 6 month PFS rate as the end point of the study.  We will also perform biomarker correlative studies that may define patients with a superior/inferior progression free survival. A number of pre-clinical and clinical investigations have provided encouraging results for the use of ENMD-2076 in the treatment of various types of cancer, including sarcoma.  We believe the co-inhibition of Aurora kinase A and angiogenesis would render ENMD-2076 an attractive and logical treatment for sarcoma.”

Ken K. Ren, Ph.D., EntreMed’s Chief Executive Officer commented, “We are excited about the initiation of this trial.  We believe ENMD-2076 has good potential in the treatment of sarcoma along with other oncology indications.  In our Phase 1 trial in solid tumors, we had one patient with advanced/metastatic sarcoma relapse after multiple lines of previous therapies, however after being treated with ENMD-2076, the patient had prolonged disease PFS for 21 months.  This Phase 2 trial will enable us to explore the potential of ENMD-2076 for this indication further. We look forward to our continued advancement and development of ENMD-2076 as an oncology platform.”

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company employing a drug development strategy primarily in the United States and China to develop targeted therapeutics for the global market.  Its lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma, and leukemia, and is currently completing a multi-center Phase 2 study in ovarian cancer.  EntreMed, Inc. recently announced the initiation of a Phase 2 study of ENMD-2076 in triple-negative breast cancer and the initiation of a Phase 2 study of ENMD-2076 in advanced/metastatic soft tissue sarcoma.  Additional information about EntreMed is available on the Company’s web site at www.entremed.com and in various filings with the Securities and Exchange Commission (the SEC).

About ENMD-2076

ENMD-2076 is an orally-active, Aurora A/angiogenic kinase inhibitor with a unique kinase selectivity profile and multiple mechanisms of action.  ENMD-2076 has been shown to inhibit a distinct profile of angiogenic tyrosine kinase targets in addition to the Aurora A kinase.  Aurora kinases are key regulators of mitosis (cell division), and are often over-expressed in human cancers.  ENMD-2076 also targets the VEGFR, Flt-3 and FGFR3 kinases which have been shown to play important roles in the pathology of several cancers.  ENMD-2076 has shown promising activity in Phase 1 clinical trials in solid tumor cancers, leukemia, and multiple myeloma.  ENMD-2076 is currently completing a Phase 2 trial for ovarian cancer.  EntreMed, Inc. recently initiated a dual-institutional Phase 2 study of ENMD-2076 in triple-negative breast cancer.

Forward Looking Statements

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act with respect to the outlook for expectations for future financial or business performance, strategies, expectations and goals.  Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and no duty to update forward-looking statements is assumed.

Actual results could differ materially from those currently anticipated due to a number of factors, including: the risk that we may be unable to continue as a going concern as a result of our inability to raise sufficient capital for our operational needs; the possibility that we may be delisted from trading on the Nasdaq Capital Market; the volatility of our common stock; the difficulty of executing our business strategy in China; our inability to enter into strategic partnerships for the development, commercialization, manufacturing and distribution of our proposed product candidate; risks relating to the need for additional capital and the uncertainty of securing additional funding on favorable terms; declines in actual sales of Thalomid® resulting in reduced royalty payments; risks associated with our product candidates; any early-stage products under development; results in preclinical models are not necessarily indicative of clinical results; uncertainties relating to preclinical and clinical trials, including delays to the commencement of such trials; the lack of success in the clinical development of any of our products; dependence on third parties; and risks relating to the commercialization, if any, of our proposed products (such as marketing, safety, regulatory, patent, product liability, supply, competition and other risks).  Such factors, among others, could have a material adverse effect upon our business, results of operations and financial condition.  We caution readers not to place undue reliance on any forward-looking statements, which only speak as of the date made. Additional information about the factors and risks that could affect our business, financial condition and results of operations, are contained in our filings with the U.S. Securities and Exchange Commission (“SEC”), which are available at www.sec.gov.

COMPANY CONTACT:
Investor Relations
EntreMed, Inc.
240.864.2643
investorrelations@entremed.com

Vistagen (VSTA) Successfully Completes Final Phase 1 Safety Study of AV-101

SOUTH SAN FRANCISCO, CA — (Marketwire) — 01/23/13 — VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced the successful completion of its final Phase 1 safety study of AV-101, a novel orally available prodrug candidate being developed for treatment of multiple conditions involving chronic neuropathic pain. The study results indicate that AV-101 is safe and well tolerated, with favorable bioavailability and pharmacokinetics.

“This important confirmation of AV-101’s safety is the final step in our Phase 1 program for AV-101,” said Shawn K. Singh, JD, VistaGen’s Chief Executive Officer. “With $8.8 million of funding from the National Institutes of Health (NIH) and outstanding strategic development and regulatory support from Cato Research Ltd., we have successfully completed the required studies enabling Phase 2 clinical development of AV-101 for multiple large market neurological diseases and conditions. In addition, recent data from the NIH suggest that the same neural pathway modified by AV-101 may be useful for treating depression. Launching a broad strategic collaboration to advance development and commercialization of AV-101 is among our key goals in 2013.”

About the Final AV-101 Phase 1 Safety Study

VistaGen’s final AV-101 Phase 1 safety study was a randomized, double-blind, placebo-controlled, dose-escalation clinical trial conducted at the University of California, San Diego (UCSD). The study involved three cohorts of healthy volunteers, each receiving multiple daily treatments of one of three dose levels of orally administered AV-101 over a 14-day period. The primary objectives of the study were to evaluate the safety, tolerability and pharmacokinetics (PK) of three different daily doses of AV-101 compared to placebo controls. A total of 46 healthy volunteers completed the study. The oral administration of AV-101 was safe and well tolerated by all subjects at all three dose levels tested. In addition, the PK of AV-101 was fully characterized across the range of three dose levels in the study. The data indicate that AV-101 had good bioavailability and a favorable PK profile.

“The primary safety and tolerability endpoints of the Phase 1 program were met. This is a very safe compound with no observed side effects,” commented Mark S. Wallace, MD, Chair of the Division of Pain Medicine, Department of Anesthesiology at UCSD and the principal investigator of the study. “AV-101 is an exciting prodrug compound that acts through a promising mechanism to treat pain. I am excited to move this compound into Phase 2 studies for the treatment of pain.”

About AV-101

Aimed at multi-billion dollar neurological disease and disorders and depression markets, AV-101, also known as “L-4-chlorokynurenine” (4-Cl-KYN), is a novel, orally available prodrug that is converted in the brain into an active metabolite, 7-chlorokynurenic acid (7-Cl-KYNA), which regulates an important neurotransmitter in the brain called the N-methyl-D-aspartate (or NMDA) receptor. A synthetic analogue of kynurenic acid, a naturally occurring neural regulatory compound, 7-Cl-KYNA is one of the most potent and selective blockers of the regulatory GlyB-site of the NMDA receptor.

VistaGen’s AV-101 IND application covers clinical development for neuropathic pain. In addition to neuropathic pain, VistaGen expects the results of its Phase 1 clinical program to be useful for supporting the development of AV-101 for other neurological disorders including depression and epilepsy.

About VistaGen Therapeutics

VistaGen is a biotechnology company applying human pluripotent stem cell technology for drug rescue, predictive toxicology and drug metabolism screening. VistaGen’s drug rescue activities combine its human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to generate novel, safer chemical variants (Drug Rescue Variants) of once-promising small molecule drug candidates. These are drug candidates discontinued by pharmaceutical companies, the U.S. National Institutes of Health (NIH) or university laboratories, after substantial investment in discovery and development, due to heart or liver toxicity or metabolism issues. VistaGen uses its pluripotent stem cell technology to generate early indications, or predictions, of how humans will ultimately respond to new drug candidates before they are ever tested in humans, bringing human biology to the front end of the drug development process.

VistaGen’s small molecule prodrug candidate, AV-101, has completed Phase 1 development for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects millions of people worldwide.

Visit VistaGen at http://www.VistaGen.com, follow VistaGen at http://www.twitter.com/VistaGen or view VistaGen’s Facebook page at http://www.facebook.com/VistaGen.

Cautionary Statement Regarding Forward Looking Statements

The statements in this press release that are not historical facts may constitute forward-looking statements that are based on current expectations and are subject to risks and uncertainties that could cause actual future results to differ materially from those expressed or implied by such statements. Those risks and uncertainties include, but are not limited to, risks related to the success of VistaGen’s stem cell technology-based drug rescue, predictive toxicology and metabolism screening activities, further clinical development and commercialization of AV-101 for chronic neuropathic pain or any other disease or condition, its ability to enter into strategic predictive toxicology, metabolism screening, drug rescue and/or drug development and commercialization collaborations and/or licensing arrangements with respect to AV-101 or any one or more drug rescue variants, risks and uncertainties relating to the availability of substantial additional capital to support its research, drug rescue, development and commercialization activities, and the success of its research and development plans and strategies, including those plans and strategies related to AV-101 and any drug rescue variant identified and developed by VistaGen. These and other risks and uncertainties are identified and described in more detail in VistaGen’s filings with the Securities and Exchange Commission (SEC). These filings are available on the SEC’s website at www.sec.gov. VistaGen undertakes no obligation to publicly update or revise any forward-looking statements.

For more information:

Shawn K. Singh, J.D.
Chief Executive Officer
VistaGen Therapeutics, Inc.
www.VistaGen.com
650-244-9990 x224
Investor.Relations@VistaGen.com

Mission Investor Relations
Atlanta, Georgia
www.MissionIR.com
404-941-8975
Investors@MissionIR.com

GlobalWise (GWIV) Comments on Balance Sheet Improvements, Channel Partners

COLUMBUS, OH — (Marketwire) — 01/23/13 — GlobalWise Investments, Inc. (OTCBB: GWIV) (OTCQB: GWIV) (www.GlobalWiseInvestments.com) and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, commented today on the Company’s recent debt to equity conversions, channel partnerships and market opportunities.

On December 31, 2012, GlobalWise converted a total of $945,729 of debt issued by the Company and its operating subsidiary, Intellinetics, Inc., into 3,152,432 restricted shares of the Company’s common stock at a price of $0.30 per share (based on the closing price of GlobalWise common stock on December 28, 2012, the immediately preceding business day).

“The conversion of debt to equity underscores the confidence of our key investors in the recent successes and future growth potential of our business,” stated Kendall D. Gill, Chief Financial Officer of GlobalWise. “As a result, we have substantially improved our balance sheet, created more flexibility in our cash flow and improved the attractiveness of the Company for shareholders and potential investors. We’re currently in discussions with remaining debt holders and expect to announce additional equity conversions in the coming weeks.”

The Company’s focus in 2012 was on the development of its channel partner program and on training and equipping new channel partners for success. As of December 31, 2012, the Company had 25 channel partners vs. 14 channel partners at the end of 2011. We added hundreds of new customers during 2012 as a result of these efforts and expect to add significantly more in 2013 when these sales channels are engaged for a full year.

“We began the transition to a channel sales model in 2011 as a part of a new strategy to leverage the strengths of our unique software platform by dramatically expanding our sales capability,” stated William J. “BJ” Santiago, CEO of GlobalWise. “With the Intellivue™ software platform now fully cloud-enabled and the addition of 25 channel sales partners, our service model is highly scalable and our software can be delivered virtually anywhere in the world. By investing time, effort and resources in our channel sales program and training strategic partners in 2012 who are already selling software solutions into our target markets, we’re now able to efficiently access an expanding universe of potential clients.”

“Our software platform and delivery model are uniquely focused on providing ECM solutions to the underserved small-to-mid-sized business (SMB) market,” continued Santiago. “According to the most recent US Census Bureau data, there are approximately 100,000 businesses in the US with 100 employees or more and over 5,000,000 businesses with fewer than 100 employees.”

According to a recent report released by Global Industry Analysts, Inc., “competition in the ECM market is a mix of a high concentration of large vendors in the top tier, and highly fragmented second tier, which includes niche players and open-source vendors. The third and fourth tier, the SMB market, is virtually unserviced.”

“In 2012 we began to reap the benefits of our channel building efforts and market opportunities. While the numbers are still being finalized and will not be released until completion of our annual audit, I’m pleased with our results for the fourth quarter ended December 31, 2012 and expect to announce annual revenue growth in line with previously announced guidance of 50-60%. We also experienced stable gross profit margins and improvements in operating profit and net income for the quarter,” continued Santiago. “More importantly, we’re seeing a significant increase in sales activity within our existing channel partners. Based upon this activity and our current growth rate, we expect 2013 to be a defining year for our Company that could result in doubling or tripling our annual revenue. We also expect to announce the addition of new national and international channel partners in the near future and believe that we will see both accelerating revenue growth and profitability in 2013.”

About GlobalWise Investments, Inc.

GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company’s flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape — virtually anything that can be digitized — in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.

For additional information, please visit the Company’s corporate website: www.GlobalWiseInvestments.com

This press release may contain “forward-looking statements.” Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.

GlobalWise Investments, Inc.
Columbus, Ohio
www.GlobalWiseInvestments.com
614-921-8170
Contact@GlobalWiseInvestments.com

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975

Central European Distribution (CEDC) Board of Directors appoints Ryan Lee as CFO

MT. LAUREL, N.J., Jan. 22, 2013 /PRNewswire/ — Central European Distribution Corporation (NASDAQ: CEDC) announced today that it had appointed Mr. Ryan Lee as Chief Financial Officer (CFO).

Mr. Lee, who had served as CFO of Russian Alcohol Group, a CEDC subsidiary, since April 2012, brings over 23 years of financial management experience in both retail and tobacco. He has worked for 13 years in Russia, five years in Switzerland, and two years in each of the UK and the Netherlands. From November 2008 to March 2012, Mr. Lee worked for Eldorado as Vice President Finance, leading the successful turnaround of one of Russia’s largest electronic retailers. From 1999-2008, Mr. Lee worked for Japan Tobacco International, Geneva as Vice President Finance, Business Service Centres & Integration, among other senior roles, including as CFO, Vice President Finance and Financial Controller for Russia.  From 1989-1999, Mr. Lee held accounting, finance and commercial positions at Unilever PLC and its group subsidiaries.

CEDC also announced that Bartosz Kołacinski agreed to resume his position as Deputy CFO of CEDC.  Mr. Kołacinski had been serving as Interim CFO of CEDC since September 2012.

About CEDC
CEDC is one of the largest producers of vodka in the world and Central and Eastern Europe’s largest integrated spirit beverage business. CEDC produces the Green Mark, Absolwent, Zubrowka, Bols, Parliament, Zhuravli, Royal and Soplica brands, among others. CEDC currently exports its products to many markets around the world, including the United States, England, France and Japan.

CEDC also is a leading importer of alcoholic beverages in Poland, Russia and Hungary. In Poland, CEDC imports many of the world’s leading brands, including Carlo Rossi Wines, Concha y Toro wines, Metaxa Liqueur, Remy Martin Cognac, Sutter Home wines, Grant’s Whisky, Jagermeister, E&J Gallo, Jim Beam Bourbon, Sierra Tequila, Teacher’s Whisky, Campari, Cinzano and Old Smuggler. CEDC is also a leading importer of premium spirits and wines in Russia with such brands as Concha y Toro, among others.

Cautionary Statements about Forward Looking
This press release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements about the expected effects of CEDC management changes announced. Forward looking statements are based on our knowledge of facts as of the date hereof and involve known and unknown risks and uncertainties that may cause the actual results, performance or achievements of CEDC to be materially different from any future results, performance or achievements expressed or implied by our forward looking statements.

Investors are cautioned that forward looking statements are not guarantees of future performance and that undue reliance should not be placed on such statements. CEDC undertakes no obligation to publicly update or revise any forward looking statements or to make any other forward looking statements, whether as a result of new information, future events or otherwise, unless required to do so by securities laws. Investors are referred to the full discussion of risks and uncertainties included in CEDC’s Form 10-K for the fiscal year ended December 31, 2011, including statements made under the caption “Item 1A. Risks Relating to Our Business,” and in other documents filed by CEDC with the United States Securities and Exchange Commission.

Contact details:

CEDC
Anna Załuska
+48 22 456 6061

Galectin (GALT) New Potential Therapy for Diabetic Kidney Disease

New Potential Therapy for Diabetic Kidney Disease: Galectin Therapeutics Announces Anti-Galectin Drug is Effective in Preclinical Studies

Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced new preclinical data on the efficacy of anti-galectin therapy on diabetic kidney disease. Treatment of diabetic mice with GR-MD-02 was found to reverse the primary kidney disease associated with diabetes, called diabetic nephropathy, the leading cause of kidney failure, dialysis and kidney transplant. GR-MD-02 is the Company’s lead galectin inhibitor in development for the treatment of liver fibrosis, including non-alcoholic steatohepatitis (NASH) liver disease.

“These data extend the potential therapeutic use of GR-MD-02 into diabetic kidney disease, a progressive disorder resulting in kidney scarring and ultimately kidney failure,” said Peter G. Traber, MD, President, Chief Executive Officer and Chief Medical Officer, Galectin Therapeutics Inc. “These findings show the broad potential of GR-MD-02 for treating organ fibrosis which positions us to develop partnerships with companies focused on kidney disease, while we continue our focus on development for the treatment of liver fibrosis.”

In the preclinical study, diabetic mice developed histological findings consistent with diabetic nephropathy, consisting of glomerular lesions in the form of diffuse mesangial matrix accumulation and proliferation. The kidneys of the diabetic mice also showed fibrosis evidenced by interstitial collagen deposition. Treatment with GR-MD-02 reduced the mesangial matrix accumulation, which suggests the drug suppressed the production and/or accumulation of extracellular matrix components. Additionally, GR-MD-02 markedly reduced the area of interstitial fibrosis. These results demonstrate the anti-fibrotic efficacy of GR-MD-02 in the kidney and its therapeutic potential in diabetic nephropathy as well as other chronic kidney diseases.

About Diabetic Kidney Disease

Diabetic Nephropathy is the leading cause of dialysis and kidney transplantation. It is a progressive kidney disease caused by angiopathy of capillaries in the kidney glomeruli. It is characterized pathologically as a diffuse glomerulosclerosis which results in proteinuria, nephrotic syndrome, progressive reduction in glomerular filtration rate, and results eventually in kidney failure. Diabetic nephropathy is due to longstanding diabetes mellitus and is the major indication for dialysis in many Western countries. While control of serum glucose level and control of blood pressure are effective in reducing the progression of diabetic nephropathy, renal failure remains a major health problem. Accordingly, there is a great need to provide therapies that are efficacious in preventing, slowing the progression or reversing diabetic nephropathy and kidney fibrosis.

About Galectin Therapeutics

Galectin Therapeutics (NASDAQ: GALT) is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company’s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer. Additional information is available at www.galectintherapeutics.com.

Forward Looking Statements

This press release contains, in addition to historical information, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or future financial performance, and use words such as “may,” “estimate,” “could,” “expect” and others. They are based on our current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in the statements. Factors that could cause our actual performance to differ materially from those discussed in the forward-looking statements include, among others: incurrence of operating losses since our inception, uncertainty as to adequate financing of our operations, extensive and costly regulatory oversight that could restrict or prevent product commercialization, inability to achieve commercial product acceptance, inability to protect our intellectual property, dependence on strategic partnerships, product competition, and others stated in risk factors contained in our SEC filings. We cannot assure that we have identified all risks or that others may emerge which we do not anticipate. You should not place undue reliance on forward-looking statements. Although subsequent events may cause our views to change, we disclaim any obligation to update forward-looking statements.

GSE Systems (GVP) Comments on Unusual Trading Activity

GSE Systems, Inc. (“GSE” or “the Company”) (NYSE MKT: GVP) announced that the New York Stock Exchange has notified the Company about significant and unusual trading activity in GSE’s shares on January 22, 2013 and requested the Company to respond by press release to the unusual activity.

Ordinarily, it is GSE’s policy not to comment on unusual market activity or market rumors; however the Company did confirm that it is not aware of any material corporate developments beyond its most recently issued news releases which could account for the recent unusual trading activity in its shares.

ABOUT GSE SYSTEMS, INC.

GSE Systems Inc. is a world leader in real-time high-fidelity simulation, providing a wide range of simulation, training and engineering solutions to the energy and process industries. Its comprehensive and modular solutions help customers achieve performance excellence in design, training and operations. GSE’s products and services are tailored to meet specific client requirements such as scope, budget and timeline. The Company has over four decades of experience, more than 1,100 installations, and hundreds of customers in over 50 countries spanning the globe. GSE Systems is headquartered in Sykesville (Baltimore), Maryland, with offices in St. Marys, Georgia; Madison, New Jersey; Cary, North Carolina; Chennai, India; Nyköping, Sweden; Stockton-on-Tees, UK; Glasgow, UK; and Beijing, China. Information about GSE Systems is available at www.gses.com.

FORWARD LOOKING STATEMENTS

We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements reflect our current expectations concerning future events and results. We use words such as “expect,” “intend,” “believe,” “may,” “will,” “should,” “could,” “anticipates,” and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project. For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the forward-looking statements and risk factors sections. We do not intend to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Daegis (DAEG) CEO to Step Down in February 2013

Daegis Inc. (NASDAQ: DAEG), an eDiscovery and information management company, today announced that Todd Wille plans to step down as President, Chief Executive Officer and member of the Board of Directors to pursue new leadership opportunities. Timothy Bacci, Executive Chairman of the Board, will serve as Interim CEO and work with Mr. Wille to ensure a smooth transition, which is expected to be completed in February 2013.

The Company further announced that Chief Financial Officer Steven Bonham will also step down in February 2013. The Board has appointed Steve Baker Interim CFO. Mr. Baker is a Partner with Tatum, a national Executive Services consulting company, with more than 25 years of experience. The Board will begin the search process, starting with the CFO, and expects to have it completed in the next 4-6 months.

Executive Chairman Timothy Bacci commented, “The Company is on course in its evolution to become a market leader with our SaaS eDiscovery and archive offerings. Starting with the hiring of our eDiscovery Division President last May, we have been planning the integration of business strategies for our eDiscovery and AXS-One archiving divisions. We believe there is growing customer demand for comprehensive information management and eDiscovery to support Big Data, analytics and Information Governance requirements. Accordingly, the board has decided to accelerate this vision and bring in the pertinent skill sets to capture new market opportunities. With the continued stability and profitability of our tools and migration businesses, strong division leadership in place, and technology advancements over the past year, we believe we are primed to drive growth, profitability, and value for our investors and customers.”

Mr. Bacci continued, “On behalf of the board, I thank Todd for his leadership, integrity and resolve in guiding Daegis over the past 12 years and solidly positioning the Company for future growth. We thank Steve for his dedication and diligence in serving the board, investors, customers, and vendors for the past seven years and through multiple acquisitions and financings. We wish Todd and Steve all the best in the future.”

“For the past 12 years, I have had the great fortune to work with a talented team of employees, board members, investors and loyal customers, and guide the Company’s growth from less than $10 million to where we are currently,” said Mr. Wille. “Today, Daegis is on a solid foundation and with strong leadership at the helm of each of the divisions, I decided that it was time for me to move on and pursue new passions.”

“The board’s decision on the timing of this leadership change was made following considerable discussion over the last several months regarding our evolution as a Company. Today’s announcement should not be taken as any positive or negative indication of the Company’s expected performance for the third quarter of fiscal 2013, which will be announced on March 7, 2013,” concluded Mr. Bacci.

Timothy Bacci Biography

Daegis Interim CEO and Executive Chairman Tim Bacci brings more than 20 years of executive experience in private and publicly traded companies. He joined the Daegis Inc. Board of Directors in 2009 and was appointed Executive Chairman in 2012. Mr. Bacci is the co-founder of BlueLine Partners, a strategic opportunities fund with more than $100 million in assets invested in small, publicly-traded, and undervalued healthcare and IT companies. Prior to BlueLine, he served in executive positions for software companies, including serving as Chairman and interim CEO of Instant802 Networks and CEO of siteROCK Corp. He was a co-founder of Vicinity Corporation, which had a successful public offering in 2000 and was subsequently acquired by Microsoft in 2002. Additionally, he has served as a consultant to several early stage technology companies addressing areas relating to corporate strategy and executive recruiting. Mr. Bacci holds a B.S. in Engineering from the United States Naval Academy and served as an officer on active duty in the U.S. Navy as a fighter pilot.

Steve Baker Biography

Steve Baker is a partner in the Northern California practice of Tatum, a national Executive Services firm that assists clients with Interim executive placements, staffing and consulting. He has over 25 years of operational and financial experience in the software and SaaS industries. Most recently, he held an Interim Executive Placement with Plug and Play Tech Center serving as advisor and mentor to its executive team. Prior to that, he was the Vice President and Chief Financial Officer for Frontrange Solutions where he directed all financial, human resources, IT functions, including managing multiple business units and debt financings. Previously, he was the Vice President of Revenue Operations for PeopleSoft, where he directed global revenue recognition, revenue accounting, credit and collections, and Sarbanes Oxley compliance activities. He also served in Vice President and CFO roles at Roamware and Geoworks Corp. Mr. Baker holds an MBA in Finance and Accounting from Columbia Graduate School of Business and a BA from the University of Pennsylvania.

About Daegis Inc.

Daegis delivers eDiscovery and information management solutions. Daegis’ eDiscovery Platform combines technology and on-demand services to deliver end-to-end and cost-effective solutions for corporations and law firms. The Company’s information management business delivers solutions for developing, managing, modernizing, and archiving applications and business data. For additional information, visit www.daegis.com.

Forward Looking Statements

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company. We wish to caution you that these statements involve risks and uncertainties and actual events or results may differ materially. When the words “believes,” “expects,” “plans,” “projects,” “estimates” and similar expressions are used, they identify forward-looking statements. These forward-looking statements are based on management’s current beliefs and assumptions and information currently available to management and involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Examples of forward-looking statements in the press release include the statements made by Mr. Bacci and Mr. Wille. Among the important factors which could cause actual results to differ materially from those in the forward-looking statements are general market and economic conditions, our ability to execute our business strategy, the effectiveness of our sales team and approach, our ability to target, analyze and forecast the revenue to be derived from a client and the costs associated with providing services to that client, the date during the course of a fiscal year that a new client is acquired, the length of the integration cycle for new clients and the timing of revenues and costs associated therewith, our client concentration given that the Company is currently dependent on a few large client relationships, potential competition in the marketplace, the ability to retain and attract employees, market acceptance of our service programs and pricing options, our ability to maintain our existing technology platform and to deploy new technology, our ability to sign new clients and control expenses, the possibility of the discontinuation of some client relationships, the financial condition of our clients’ business and other factors detailed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise the information in this press release, whether as a result of new information, future events, circumstances or otherwise.

Chanticleer Holdings (HOTRW) Provides Corporate Update

CHARLOTTE, NC–(Marketwire – January 22, 2013) – Chanticleer Holdings, Inc. (NASDAQ: HOTR) (NASDAQ: HOTRW) (“Chanticleer Holdings” or the “Company”), a minority owner in the privately-held parent company of the Hooters® brand, Hooters of America (“HOA”), and a franchisee of international Hooters restaurants, today provided a corporate update on its business, operational initiatives, and roll-out plan.

The past two years have been very eventful for Chanticleer Holdings. In January 2011, Chanticleer and a group of private equity investors acquired HOA, five years after the Company made its original investment in HOA and subsequent to the death of Mr. Bob Brooks, the founder and former owner of HOA. In October 2011, the Company acquired the majority ownership in its first three South African Hooters restaurants. Concurrently, the Company formed its own management company to operate all Hooters® restaurants in South Africa. In 2012, the Company opened three additional Hooters restaurants in Campbelltown, Australia, Emperor’s Palace, South Africa, and Budapest, Hungary.

Emperor’s Palace was the first restaurant opened under the complete leadership of Chanticleer Holdings and Gordon Jestin, Chief Operating Officer of its South African subsidiaries (“Hooters South Africa”). Emperor’s Palace has proven to be a successful and profitable restaurant, indicating the Hooters brand can be successful in South Africa. The Company plans to open its next South African restaurant in Pretoria in the first half of 2013.

For 2013, the Company is focused on achieving same store sales growth, increasing consolidated gross margin to 62% from 58.2%, increasing overall profitability, and expanding its number of Hooters® restaurants. The Company has already initiated and taken steps to improve same store sales growth and gross margin for 2013. In December, Hooters South Africa implemented price increases of 7% for all food items and 5% for all liquor, where this new pricing still reflects competitive pricing in the current marketplace. Hooters South Africa also updated its menu offerings by removing slow moving items and adding new offerings appealing to women. Hooters South Africa has added two new salads to the menu, expanded wrap offerings, added a “ladies cut” steak, and has given guests the option to purchase a smaller portion of curly fries to add to their main course. During the fourth quarter of 2012, Hooters South Africa experienced an improvement in same store sales, where the Company attributes this growth to the leadership of its Chief Operating Officer in South Africa and the guidance and support of HOA.

In addition to improvements to the menu, the Company continues to improve the appeal of its restaurants to meet the wants and needs of its Hooters® guests. During the fourth quarter of 2012, the Durban, South Africa restaurant increased its number of seats by 25, which is expected to increase revenues on its busier weekend nights. This additional seating also helped create a private area for functions of 30 to 40 guests. Also during the fourth quarter of 2012, the Johannesburg, South Africa restaurant invested in additional televisions to improve the guest experience. The Company also plans to improve its brand loyalty by rewarding its loyal patrons with the launch of a Hooters® loyalty program in the first quarter of 2013.

The Company has also begun operational initiatives at the Hooters of Budapest, in Hungary, to reduce costs, increase profitability, and increase guest traffic. During the fourth quarter of 2012, Hooters of Budapest began its initiative to reduce labor costs. During the first quarter of 2013, Hooters of Budapest will be launching its Efficient Operating Network, a tool developed, requiring daily, weekly, and monthly reporting and maintenance, to lower cost of sales and labor and improve overall operational efficiency. To increase guest traffic, Hooters of Budapest will be hosting its first tequila party, bike night, Valentine’s Day blowout, and launching its “Girls of Budapest” pictorial. Hooters of Budapest also plans to open its outdoor patio, adding 140+ seats, increasing restaurant seating by 56% to a total of 390 seats, in time for tourist season, beginning in April through October. Budapest, Hungary is one of the most popular tourist destinations in central Europe.

The Company has also focused on improving its internal operations. During the fourth quarter, the Company hired in-house counsel and hired a highly experienced CFO for its South African subsidiaries. As a result of the previously disclosed Audit Committee investigation, the Company is also in the process of implementing certain new internal controls which will provide better checks and balances for financial reporting. The Company’s CFO, Eric Lederer, will spend nine days in South Africa beginning on January 26th, 2013, to assist with the 2012 audit, review internal controls being implemented, observe operations, and also focus on our gross profit improvement initiatives. Marcum LLP is also scheduled to travel to South Africa beginning January 26, 2013 to begin their audit for the year ended December 31, 2012.

Separately, at the request of the NASDAQ Staff, the Company has hired Watermark Auditors, a South African affiliate of RBSM LLP, to re-test its controls over financial reporting prior to Mr. Lederer’s arrival, to determine how operations have changed since the conclusion of the Audit Committee’s investigation, and to provide any suggestions on continued improvement. Watermark Auditors will assist management in reviewing the Company’s South African subsidiaries’ controls each quarter to see that all previously suggested improvements to internal controls are fully implemented and effective by November of this year.

Following the previous disclosure of misconduct by Mr. Hezlett, the former CFO of Hooters South Africa, a lawsuit was filed against the Company in October 2012. The Company has hired experienced legal counsel to assist with a timely and proper resolution of the lawsuit.

The Company is continuing to move forward with its development plan. The Company expects to secure a long awaited site in Rio de Janeiro, Brazil within the first quarter of 2013 and open a restaurant in Pretoria, South Africa in the first half of 2013. The Company’s Campbelltown, Australia location became profitable in the third quarter of 2012, giving confidence that the new Surfers Paradise, Australia location could be a success. After finding a better opportunity for the Surfer’s Paradise location, a new lease agreement has been entered into, pending HOA approval. Construction is set to commence at this location after receipt of HOA approval, which is expected mid-February 2013. The Company plans to increase the number of restaurants operating in 2013 to a total of 10 restaurants as compared to 6 total restaurants operating at 2012 year-end.

Mike Pruitt, President and CEO of Chanticleer Holdings, commented, “I regret to have inconvenienced our shareholders during the trading halt, and am pleased NASDAQ has determined to allow the Company’s common shares and warrants to have resumed trading last week. We continue to remain confident in the fundamentals of our business and the Hooters® brand. We are committed to generating same store sales growth, improving profitability, and developing new Hooters restaurants in our exclusive international franchise territories. While we remain in the early stages of developing our territories of Europe and Brazil, we have made considerable investments in them, laying the foundation for growth opportunities we see continuing for the foreseeable future.”

About Chanticleer Holdings, Inc.
Chanticleer Holdings is focused on expanding the Hooters® casual dining restaurant brand in international emerging markets. Chanticleer currently owns in whole or part of the exclusive franchise rights to develop and operate Hooters restaurants in South Africa, Hungary and parts of Brazil, and has joint ventured with the current Hooters franchisee in Australia, while evaluating several additional international opportunities. The Company currently owns and operates in whole or part of six Hooters restaurants in its international franchise territories: Durban, Johannesburg, Cape Town and Emperor’s Palace in South Africa; Campbelltown in Australia; and Budapest in Hungary.

In 2011, Chanticleer and a group of noteworthy private equity investors, which included H.I.G. Capital, KarpReilly, LLC and Kelly Hall, president of Texas Wings Inc., the largest Hooters franchisee in the United States, acquired Hooters of America (HOA), a privately held company. Today, HOA is an operator and the franchisor of over 430 Hooters® restaurants in 28 countries. Chanticleer maintains a minority ownership stake in HOA and its CEO, Mike Pruitt, is also a member of HOA’s Board of Directors. For further information, please visit www.chanticleerholdings.com or www.hooters.com and follow us on Twitter at @ChantHoldings or @Hooters.

Forward-Looking Statements:
Any statements that are not historical facts contained in this release are “forward-looking statements” as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as “expects,” “plans,” “projects,” “will,” “may,” “anticipates,” “believes,” “should,” “intends,” “estimates,” and other words of similar meaning. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include those described in the companies’ filings with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date the statements were made, and the companies do not undertake any obligation to update forward-looking statements. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

Company Contact:
Shannon DiGennaro
V.P. Investor Relations
Phone: 704.941.0959
sd@chanticleerholdings.com

Inventergy Global, Inc. (INVT)

Inventergy Global, Inc. is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.

With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.

Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.

The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value.

Key Investment Highlights

• Applying decades of IP and business expertise and best practices
• Integrating technology and market expertise to achieve fair IP value
• Strong history of structuring IP licensing and vale creation strategies
• Growing portfolio of more than 760 telecommunication patents

Eurasian Minerals (EMXX) Drills the Highest Grade Intercept to Date

Eurasian Minerals Drills the Highest Grade Intercept to Date of 2.15 Meters Averaging 89.34 g/t Gold and 835.16 g/t Silver at the Akarca Project, Northwest Turkey

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Jan. 18, 2013) – Eurasian Minerals Inc. (the “Company” or “EMX”) (TSX VENTURE:EMX)(NYSE MKT:EMXX) is pleased to announce results from the first two holes of the 2012-2013 drill campaign at the Akarca gold-silver project in northwest Turkey. The results include an oxide intercept starting at surface of 36.4 meters averaging 5.67 g/t gold and 53.31 g/t silver, with a sub-interval of 2.15 meters averaging 89.34 g/t gold and 835.16 g/t silver that represents the highest grade intercept drilled to date on the property (true widths interpreted as 60-75% of reported interval length). The bonanza intercept highlights the project’s high-grade gold-silver exploration potential. In addition, the Company’s recent programs of geologic mapping and surface sampling have identified several new zones of gold-silver mineralization for follow-up drilling.

Akarca is 100% controlled by EMX, and is available for partnership. The Company is currently in advanced discussions with a number of potential partners interested in the property. Please see the attached map for more information.

Current Program Results. EMX initiated a drill program in December, 2012 to test new target concepts, as well as extend gold-silver mineralization identified from previous exploration. The first two holes were drilled at the Sarikaya Tepe prospect, which is a zone of surface-exposed quartz veining, silicification, and gold-silver mineralization coincident with a steep north-northwest trending ridge. A summary of drill results from Sarikaya Tepe are given in the table below.

Previous drilling at Sarikaya Tepe was angled across the zone from the west due to a lack of access from the top of the ridge. For the current campaign, EMX constructed a drill road on the top of Sarikaya Tepe and during excavation a new, 200 meter long, conglomerate-hosted zone of veining and silicification was discovered on the east side of the prospect. This new zone is an additional target for follow-up exploration.

Elsewhere on the property, EMX continued with geologic mapping, soil sampling, drill road construction, and trenching (please refer to map: http://media3.marketwire.com/docs/EMX0118.pdf).

• Recent extensions to soil sample grids identified new vein and silicified zones north of Sarikaya Tepe and west of Percem Tepe.
• Drill road construction at Fula Tepe exposed a broad corridor of silicification, quartz veining and mineralization. Trench samples across the Fula Tepe trend yielded nearly continuous mineralization along 200 meters of drill road, including 168.6 m @ 0.66 g/t gold with 8.66 g/t silver, and 7 m @ 5.29 g/t gold with 27.61 g/t silver. To the north, additional across-trend sampling extended the width of Fula Tepe with trench intervals of 38.2 m @ 1.19 g/t gold with 6.70 g/t silver, and 20 m @ 0.29 g/t gold with 3.17 g/t silver. Trench sampling to the south further broadened the mineralized corridor with 31.3 m @ 0.65 g/t gold.
• Drill road construction at Arap Tepe exposed silicification, quartz veining and mineralization that extended the overall width of the zone at surface. Follow-up trench sampling across the zone returned gold intervals of 55.5 m @ 1.27 g/t and 14.5 m @ 0.42 g/t from one drill road, and 38.5 m @ 0.29 g/t and 23.5 m @ 0.26 g/t from a second road exposure.

EMX’s recent exploration work has returned a bonanza grade drill intercept, discovered new vein zones from mapping and sampling, and identified extensions to known zones of mineralization. These ongoing exploration successes underscore the upside, district-scale exploration potential of the Akarca property.

Akarca Overview. The Akarca project is an EMX grassroots discovery consisting of six separate gold-silver mineralized zones occurring within a district-scale area. Gold and silver mineralization occurs as both structurally focused vein-style, as well as disseminated-style mineralization in silicified zones. The quartz veins typically host higher-grade mineralization, while the silicified halos in the wall-rocks host lower-grade disseminated mineralization. In addition, mineralization is hosted at the intersection of vein structures and the underlying basement contact, significantly increasing the project’s exploration potential.

To date, 83 drill holes totaling over 10,000 meters, 3,100 rock and 3,300 soil geochemical samples, 74 line-kilometers of IP-resistivity surveys, and a property-wide gravity survey have been completed. Less than 20% of the 14,000 meters of vein target strike length as currently defined by mapping and IP-resistivity anomalies have been drill tested to date, with additional gold-silver zones continuing to be discovered.

Additional EMX Properties in Turkey Available for Partnership. EMX’s Alankoy high-sulfidation/porphyry copper-gold project is available for partnership. The property is located in the vicinity of the recently discovered Halilaga porphyry copper-gold deposit and the Kirazli project in northwest Turkey. Shallow historic drilling at Alankoy was focused on epithermal gold targets, but one hole drilled in the center of the system ended in copper mineralization.

Comments on Sampling, Assaying, and QA/QC. EMX’s drill and geochemical samples were collected in accordance with accepted industry standards. The samples were submitted to ALS Chemex laboratories in Izmir, Turkey (ISO 9001:2000) and Vancouver, Canada (ISO 9001:2000 and 17025:2005 accredited) for sample preparation and analysis. Gold was analyzed by fire assay with an AAS finish, and silver underwent aqua regia digestion and analysis with MS/AES techniques. Over limit assays for gold (> 10 g/t Au) were conducted with fire assay and a gravimetric finish. As standard procedure, the Company conducts routine QA/QC analysis on all assay results, including the systematic utilization of certified reference materials, blanks, and field duplicates.

About EMX. Eurasian is a global gold and copper exploration company utilizing a partnership business model to explore the world’s most promising and underexplored mineral belts. Eurasian generates wealth via grassroots prospect generation, strategic acquisition and royalty growth.

Mr. Michael P. Sheehan, CPG, a Qualified Person as defined by National Instrument 43-101 and employee of the Company, has reviewed and verified the technical information contained in this news release.

Forward-Looking Statements

This news release may contain “forward looking statements” that reflect the Company’s current expectations and projections about its future results. When used in this news release, words such as “estimate”, “intend”, “expect”, “anticipate”, “will” and similar expressions are intended to identify forward-looking statements, which, by their very nature, are not guarantees of the Company’s future operational or financial performance, and are subject to risks and uncertainties and other factors that could cause Eurasian’s actual results, performance, prospects or opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. These risks, uncertainties and factors may include, but are not limited to: unavailability of financing, failure to identify commercially viable mineral reserves, fluctuations in the market valuation for commodities, difficulties in obtaining required approvals for the development of a mineral project, increased regulatory compliance costs, expectations of project funding by joint venture partners and other factors.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release or as of the date otherwise specifically indicated herein. Due to risks and uncertainties, including the risks and uncertainties identified in this news release, and other risk factors and forward-looking statements listed in the Company’s MD&A for the nine-month period ended September 30, 2012 (the “MD&A”) and most recently filed Annual Information Form for the nine-month period ended December 31, 2011 (the “AIF”), actual events may differ materially from current expectations. More information about the Company, including the MD&A, the AIF and financial statements of the Company, is available on SEDAR at www.sedar.com and on the SEC’s EDGAR website at www.sec.gov.

Contact Information:
Eurasian Minerals Inc.
David M. Cole
President and Chief Executive Officer
(303) 979-6666
Dave@EurasianMinerals.com

Eurasian Minerals Inc.
Valerie Barlow
Corporate Secretary
(604) 688-6390
(604) 688-1157 (FAX)
Valerie@EurasianMinerals.com
www.EurasianMinerals.com

BGC Partners (BGCP) Announces Its 2013 Annual Meeting of Stockholders

To be held on Tuesday, June 4, 2013 at 10:00 a.m. ET Webcast available for investors

NEW YORK, Jan. 18, 2013 /PRNewswire/ — BGC Partners, Inc. (NASDAQ: BGCP) (“BGC Partners,” “BGC” or “the Company”), a leading global brokerage company primarily servicing the wholesale financial and real estate markets, today announced that it currently plans to hold its 2013 Annual Meeting of Stockholders on Tuesday, June 4, 2013, at 10:00 a.m. ET at the Company’s executive offices in New York City.  The meeting will include a brief discussion of BGC’s business by Chairman and Chief Executive Officer, Howard W. Lutnick. Revised deadlines for proposals by stockholders for the Annual Meeting will be included on a filing on Form 8-K attaching this release.

(Logo: http://photos.prnewswire.com/prnh/20110720/MM38935LOGO )

A live audio webcast of the event will start at approximately 10:00 a.m. ET and is expected to last approximately one hour. It will also be available via the following site:
http://www.bgcpartners.com/ir

The webcast archive will be available for 365 days, beginning June 4, 2013.

(Note: If clicking the above link does not open up a new web page, you may need to cut and paste the above url into your browser’s address bar.)

About BGC Partners, Inc.

BGC Partners is a leading global brokerage company primarily servicing the wholesale financial and real estate markets.  Products include fixed income securities, interest rate swaps, foreign exchange, equities, equity derivatives, credit derivatives, commercial real estate, commodities, futures, and structured products. BGC also provides a wide range of services, including trade execution, broker-dealer services, clearing, processing, information, and other back-office services to a broad range of financial and non-financial institutions.  Through its eSpeed, BGC Trader, and BGC Market Data brands, BGC offers financial technology solutions, market data, and analytics related to select financial instruments and markets.  Through the Newmark Grubb Knight Frank brand, the Company offers a wide range of services including leasing and corporate advisory, investment sales and financial services, consulting, project and development management, and property and facilities management. BGC’s customers include many of the world’s largest banks, broker-dealers, investment banks, trading firms, hedge funds, governments, corporations, property owners, real estate developers, and investment firms. For more information, please visit www.bgcpartners.com.

eSpeed, BGC, BGC Trader, Grubb & Ellis, Grubb and Newmark are trademarks and service marks of BGC Partners, Inc. and its affiliates.  Knight Frank is a service mark of Knight Frank Limited Corp., used with permission.

Discussion of Forward-Looking Statements by BGC Partners, Inc.

Statements in this press release regarding BGC Partners’ business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see BGC Partners’ Securities and Exchange Commission filings, including, but not limited to, the risk factors set forth in its public filings, including its most recent Form 10-K and any updates to such risk factors contained in subsequent Form 10-Q or Form 8-K filings.

Atossa (ATOS) to Present at NINE 2013 – Noble Financial Conference

SEATTLE, WA — (Marketwire) — 01/18/13 — Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Kyle Guse, chief financial officer, general counsel and secretary, will present at the NINE 2013 – Noble Financial Capital Markets’ Ninth Annual Equity Conference held at the Hard Rock Hotel & Casino, Hollywood, Florida, on Tuesday, January 22, at 3:00 pm Eastern Time. A webcast of the presentation will be available on Atossa’s web site at www.atossagenetics.com.

Mr. Guse stated, “I look forward to participating in this prestigious conference and presenting the Atossa Genetics story to investors. My presentation will include a discussion of the recently announced national rollout of our ForeCYTE Breast Health Test, further commercialization of our ArgusCYTE Breast Health Test, advancement of two additional tests and of the planned clinical development of our intraductal therapeutic for treatment of pre-cancerous cellular changes as a means to potentially prevent breast cancer.”

About Atossa Genetics, Inc.

Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, is based in Seattle, Washington, and is focused on preventing breast cancer through the commercialization of patented, FDA-cleared diagnostic medical devices and patented, laboratory developed tests (LDT) that can detect precursors to breast cancer up to eight years before mammography, and through research and development that will permit it to commercialize treatments for pre-cancerous lesions.

The National Reference Laboratory for Breast Health (NRLBH), a wholly owned subsidiary of Atossa Genetics, Inc., is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, WA, that provides the patented ForeCYTE Breast Health Test, a risk assessment test for women 18 to 73 years of age akin to the Pap smear, and the ArgusCYTE Breast Health Test, a blood test for recurrence in breast cancer survivors that provides a “liquid biopsy” for circulating cancer cells and a tailored treatment plan for patients and their caregivers.

Forward-Looking Statements

Except for the historical information contained herein, the matters set forth in this press release, including statements regarding Atossa’s plans, expectations, projections, potential opportunities, goals and objectives are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with the efficacy of Atossa’s products and services, the market demand for and acceptance of Atossa’s products and services and other risks detailed from time to time in the Atossa’s final prospectus, dated November 7, 2012, filed with the U.S. Securities and Exchange Commission and other filings with the SEC. All forward-looking statements are qualified in their entirety by this cautionary statement, and Atossa undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:

Atossa Genetics, Inc.
Steven C. Quay, M.D., Ph.D., FCAP
Chairman, President and CEO of Atossa Genetics and
Director of the National Reference Laboratory for Breast Health
800-351-3902
Email Contact

Matthew D. Haines (Investors and Media)
Managing Director
MBS Value Partners
212-710-9686

TigerLogic (TIGR) and Storycode Complete Merger

IRVINE, Calif., Jan. 18, 2013 /PRNewswire/ — TigerLogic Corporation (Nasdaq: TIGR) today confirmed the closing of its previously announced acquisition of privately held Storycode, Inc., a mobile app publishing studio, effective January 17, 2013.

“We believe the combination of TigerLogic’s Postano social visualization platform and Storycode will create a social platform with unique mobile distribution capabilities,” said Richard Koe, President and CEO, TigerLogic. “This new platform will allow brands to use original and fan-generated content to develop engaging experiences across web, events, and mobile environment to drive improved consumer loyalty with visually based engagement in real-time. In addition to the complimentary technology, Storycode will add recognized expertise in areas of user experience, data visualization, and creative services.”

James McDermott, former chief executive officer of Storycode, has been appointed as TigerLogic’s Senior Vice President, Mobile and Social, and Justin Garrity, former chief creative officer of Storycode, has assumed the role of Vice President, Product and Marketing.

Conference Call

TigerLogic will hold a conference call to discuss the merger on January 22, 2013 at 4:30 p.m. Eastern Time.

The call can be accessed by dialing 1-877-481-4996 (Domestic) or 1-518-444-5106 (International), and by providing the operator the conference ID number 90770506.

A taped rebroadcast of the call will be available approximately two hours after the call through January 29, 2013. To access the taped rebroadcast, dial 1-855-859-2056/1-800-585-8367 (Domestic) or 1-404-537-3406 (International), and enter security code 012213 and conference ID number 90770506.

The call will also be archived for two weeks in the Press Release section of TigerLogic’s website at: http://www.tigerlogic.com/tigerlogic/company/press/index.jsp.

About TigerLogic Corporation
TigerLogic Corporation (Nasdaq: TIGR) is a global provider of data management and application development solutions for enterprises that need to launch easy and cost-effective e-business initiatives. TigerLogic’s installed customer base includes more than 500,000 active users representing more than 20,000 customer sites worldwide, who rely on TigerLogic’s offerings for multidimensional database management, rapid application development, search enhancement, as well as content aggregation, syndication and a mobile publishing platform, which platform includes such customers as The University of Oregon Athletic Department, Nine West, Owens Illinois, Tommy Hilfiger, Entrepreneur Media, The Independent, Mindjet, CBS, NBC, and Thomson Reuters. Built on proven technology, TigerLogic helps control data and content and transform them into business intelligence and engagement. More information about TigerLogic and its products can be found at http://www.tigerlogic.com.

The foregoing release contains forward-looking information, including statements about the expected synergies from the Storycode acquisition transaction and the anticipated development and benefits of integrated products and capabilities. Any forward-looking statements are subject to risks and uncertainties, and actual results could differ materially due to several factors, including but not limited to TigerLogic’s ability to successfully integrate the Storycode technology and employees and to realize the anticipated synergies, the success of the combined companies research and development efforts to develop new products and to penetrate new markets, the market acceptance of the  new products and updates, technical risks related to such products and updates, TigerLogic’s ability to maintain market share for its existing products, the availability of adequate liquidity and other risks and uncertainties. Please consult the various reports and documents filed by TigerLogic with the U.S. Securities and Exchange Commission, including but not limited to the most recent reports on Form 10-K and Form 10-Q for factors potentially affecting TigerLogic’s future financial results. All forward-looking statements are made as of the date hereof and TigerLogic disclaims any responsibility to update or revise any forward-looking statement provided in this news release.

TigerLogic, Postano, yolink, Raining Data, Pick, mvDesigner, D3, mvEnterprise, mvBase, Omnis, and Omnis Studio are trademarks of TigerLogic Corporation. Storycode is a trademark of Storycode, Inc. All other trademarks and registered trademarks are properties of their respective owners.

Magellan (MPET) Announces the Repurchase of 17% of its Common Stock

DENVER, Jan. 17, 2013 /PRNewswire/ — Magellan Petroleum Corporation (“Magellan” or the “Company”) (NASDAQ: MPET) (ASX: MGN) today announced that on January 14, 2013, the Company entered into a Collateral Purchase Agreement with Sopak AG (“Sopak”), a Swiss subsidiary of Glencore International plc.  Under the terms of this agreement, Magellan agreed to purchase from Sopak 9,264,637 shares of Magellan’s common stock and a warrant granting Sopak the right to purchase from the Company an additional 4,347,826 shares of common stock.  In exchange for the shares and the warrant, Magellan paid to Sopak $10 million in cash consideration, which the Company funded from its own balance sheet resources.

Excluding the warrant, the shares repurchased from Sopak represent approximately 17% of the Company’s shares outstanding immediately prior to the transaction.  As of today, the Company’s outstanding shares total 44,642,983.

J. Thomas Wilson, President and CEO of Magellan, stated, “This transaction is a significant milestone in our path to deliver value to our shareholders.  We have succeeded in buying back a substantial amount of our own stock at an attractive price.  At the same time, we have eliminated the overhang from the warrant, which could have had a significant dilutive impact on our share value and shareholders.  With this transaction now behind us, we remain focused on achieving a number of operational milestones over the coming months in line with our strategy of proving up the value of our existing assets.”

Sopak originally obtained the shares and warrant in September 2012 by exercising its rights under a pledge and security agreement between Sopak and Young Energy Prize S.A., a Luxembourg corporation.

The Company has disclosed further details of this transaction on Form 8-K filed with the U.S. Securities and Exchange Commission on January 17, 2013.  This Form 8-K is also available on the Company’s website at www.magellanpetroleum.com.

CAUTIONARY INFORMATION ABOUT FORWARD LOOKING STATEMENTS

Statements in this release that are not historical in nature are intended to be, and are hereby identified as, forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995.  These statements about Magellan may relate to its businesses, prospects, and other matters that involve a number of risks and uncertainties that may cause actual results to differ materially from the results expressed or implied in the forward-looking statements.  Among these risks and uncertainties are: (i) whether repurchase of the shares and the warrant will impact our share value or shareholders; and (ii) those set forth in the Risk Factors sections of Magellan’s most recent 10-K and subsequent 10-Qs filed with the SEC.

ABOUT MAGELLAN
Magellan is an independent energy company engaged in the exploration, development, production, and sale of crude oil and natural gas from currently held assets in the United States, Australia, and the United Kingdom.  Traded on NASDAQ since 1972, the Company conducts its operations through two wholly owned subsidiaries, Nautilus Poplar LLC, which owns interests at Poplar, a highly attractive oil field in the Williston Basin, and Magellan Petroleum Australia Limited, a successful independent oil and gas company in Australia and the UK in existence since the 1964.  The Company’s mission is to enhance shareholder value by maximizing the full potential of existing assets.  Magellan routinely posts important information about the Company on its website at www.magellanpetroleum.com.

For further information, please contact:
Matthew Ciardiello, Manager, Investor Relations at 720.484.2404

Pacific Booker Minerals (PBM) Reiterates 2009 Feasibility Study Results

VANCOUVER, British Columbia, Jan. 17, 2013 /PRNewswire/ — Pacific Booker Minerals Inc. (NYSE MKT: PBM), (BKM.V) Reiterates a positive Feasibility Study, as defined by National Instrument 43-101, was released by the Company for its 100% owned Morrison Copper/Gold Project in February 2009. The study described the scope, design and financial viability of a conventional open pit mine with a 30,000 tonnes per day mill with a 21 year mine life.

The proven and probable mineable reserve was estimated to be 224.25 Mt with an average grade of 0.33% Copper, 0.163 g/t Gold and 0.004% Molybdenum. The Capital cost estimate was CDN $516.68 million (including a CDN $59.92 million contingency allocation) and operating cost was CDN $8.15 per tonne milled over the life of the mine. The Pre-Income Tax Internal Rate of Return (“IRR”) was 20.05%, based on metal prices of (four year trailing average as of January 12, 2009) Copper ($2.75), Gold ($658.32) and Molybdenum ($29.23). The Net Present Value (“NPV”) at 8.0% discount rate was CDN $495.9M.

Using a 5.0% discount rate, the NPV based on the Feasibility Study is estimated to be CDN $790M. The Feasibility Study used historical four-year average metal prices calculated as of January 12, 2009. The current upward trend in metal prices has resulted in metals trading at prices that are currently higher than their respective four year average price with the exception of molybdenum, which is lower. The CDN to US dollar exchange rate has increased since the Feasibility Study.

Silver was not included in the financial analysis; however, there is an opportunity for improved economic performance if silver credits are received from the treatment and refining of the copper concentrate. Metallurgical test-work to date has reported silver present in the concentrate. The Company’s current share capital is 14.9 M shares fully diluted including 250,000 common voting shares to be issued to Xstrata (formerly Noranda, Falconbridge) upon the start of commercial production as part of the purchase agreement with Noranda.

The mineral reserve estimates have been prepared and classified in accordance with CIM Classification established under National Instrument 43-101 of the Canadian Securities Administrators. The reserve estimate takes into consideration all geologic, mining, milling and economic factors and is stated according to Canadian Standards (NI 43-101). Under US standards, no reserve declaration is possible until financing and permits are acquired.

The Company wishes to emphasize that it is strongly committed to continue to work towards bringing the proposed Morrison Copper/Gold Project to commercial production.

If you would like to be added to our email newsgroup, please send your request by email to info@pacificbooker.com.

Contact:

Gregory R Anderson
Director, CEO and President
1-800-747-9911
1-800-324-3680

Dot Hill (HILL) to Present at Noble Financial Capital Markets’ 9th Annual Equity Conference

LONGMONT, Colo., Jan. 17, 2013 (GLOBE NEWSWIRE) — Dot Hill Systems Corp. (Nasdaq:HILL), a leading provider of SAN storage solutions, announced Hanif Jamal, chief financial officer, will present at “NINE”, Noble Financial Capital Markets’ Ninth Annual Equity Conference at the Hard Rock Hotel in Hollywood, Florida, on Wednesday, January 23, at 11:30 a.m. Eastern Time.

At the time of the presentation, a live audio and high-definition video webcast of Dot Hill’s presentation and a copy of the presentation materials will be available on the Company’s web site www.dothill.com, or through the Noble Financial websites: www.noblefcm.com, or www.nobleresearch.com/NINE/home.htm. The Company recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will also be archived on Dot Hill’s website for 90 days following the event.

About Dot Hill

Delivering innovative technology and global support, Dot Hill empowers the OEM and channels community to bring unique storage solutions to market, quickly, easily and cost-effectively. Offering high performance and industry-leading uptime, Dot Hill’s RAID technology is the foundation for best-in-class storage solutions offering enterprise-class security, availability and data protection. The Company’s products are in use today by the world’s leading service and equipment providers, common carriers and advanced technology and telecommunications companies, as well as government agencies and small and medium enterprise customers. Dot Hill solutions are certified to meet rigorous industry standards and military specifications, as well as RoHS and WEEE international environmental standards. Headquartered in Longmont, Colorado, Dot Hill has offices and/or representatives in China, Germany, Japan, United Kingdom, Singapore and the United States. For more information, visit us at http://www.dothill.com.

The Dot Hill Systems Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13870

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120 – 150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com.

HILL-F

CONTACT: Hanif Jamal
         Chief Financial Officer
         Tel: 303-845-3377
         Email: investors@dothill.com

         Jodi Bochert
         Investor Relations
         Tel:  303-845-3469
         Email:  investors@dothill.com

         Becky Herrick & Kirsten Chapman
         LHA Investor Relations
         Tel: 415-433-3777
         Email: dothill@lhai.com

NewLead (NEWL) to Acquire Properties with Estimated Coal Reserves of 18.6 Million Tons

NewLead Holdings Ltd. Announces Signing Agreement to Acquire Properties with Estimated Coal Reserves of 18.6 Million Tons; Signing Agreement to Acquire Properties with Estimated Coal Reserves of 143.1 Million Tons and Securing 3-year Coal Supply Contracts Expected to Generate $873.5 million of Revenue

PIRAEUS, Greece, Jan. 17, 2013 /PRNewswire/ — NewLead Holdings Ltd. (NASDAQ: NEWL) (“NewLead”) today announced that the Company has entered into an agreement to acquire title and excavation rights in properties containing 18.6 million tons of estimated coal reserves for $11.0 million. NewLead also entered into an agreement to acquire ownership and leasehold interests in properties containing approximately 143.1 million tons of coal for $55.0 million.

Michael Zolotas, President and Chief Executive Officer of NewLead, stated, “We have expanded our recently launched commodities business with the agreement to acquire an estimated 18.6 million tons of coal reserves.  We are in the process of acquiring additional coal properties with reserves estimated at approximately 143.1 million tons.  Once we have acquired all of the assets, our coal reserves will consist primarily of sub bituminous B coal, which is 13,500 BTU with low sulfur. We will also have ‘Blue Gem’ and ‘Rich Mountain’ seams of coal, highly sought after in the international market. We believe that our international shipping expertise will allow us to exploit the demand for these coal reserves.”

Michael Zolotas continued, “In entering the mining business, we undertook to secure supply contracts for the coal reserves.  Consequently, we entered into two agreements to supply coal to third parties.  These agreements are expected to generate $873.5 million of revenue over a three-year period. Based on our projections of operating costs, we believe that these sales will have healthy margins and will generate significant cash flow with which to fund continued growth.  We intend to supplement the supply agreements by allowing contract miners to mine and pay us a royalty for coal removed.”

Coal and Natural Gas Reserve Acquisitions
As of December 28, 2012, NewLead entered into an agreement to acquire title and mineral excavation rights to 5,000 acres of land in Kentucky.  The coal reserves in these properties are estimated to be approximately 18.6 million tons. The transaction is subject to execution and delivery of certain definitive agreements and other closing conditions, but is currently expected to close by January 29, 2013. There can be no assurance that the transaction will be consummated. The consideration of $11.0 million was paid in the form of notes maturing on January 29, 2013. The notes do not accrue interest, but remain subject to a guaranty by the initial purchaser and are secured by a mortgage lien and a security interest in the assets being purchased.

NewLead has also entered into an agreement to acquire ownership and leasehold interests in 18,335 acres in Tennessee containing coal and natural gas and other natural resources.  The agreement contemplates that the Company will acquire rights, title, permits and leases to coal mines with total reserves estimated at 143.1 million tons. The transaction is subject to execution and delivery of certain definitive agreements and other closing conditions, but is currently expected to close in February 2013. There can be no assurance that the transaction will be consummated. The agreement contemplates that consideration of $55.0 million shall be payable in cash in two installments; $30.0 million at closing and the remaining $25.0 million on the first anniversary of the closing.

The estimated reserves stated above are as determined by independent appraisals. The methodology used by the independent appraisers was not compliant with the methodology required by the Securities and Exchange Commission (“SEC”) in reserve reports and, accordingly, should not be relied upon. Such reserve information is only provided to give the best currently available information. NewLead is undertaking to obtain reserve reports that comply with SEC methodology. Such reports may differ materially from the information provided herein.

The properties in Tennessee and Kentucky also include natural gas wells and projects relating to extraction of timber, sand, gravel, fly ash and dimension stone. Third parties are currently extracting these commodities on the properties and paying royalties.

Coal Supply Contracts
NewLead signed two coal supply contracts with creditworthy counterparties for the sale of coal to such parties. Annual revenue from these two contracts is expected to be $184.7 million in the first year, $318.4 million in the second year and $370.4 million for the third and final year.

The first contract provides for the sale of 70,000 tons of coal per month for the first 12 months (840,000 tons annually), increasing to 140,000 tons per month for the second year (1.68 million tons annually) and 210,000 tons per month for the third year (2.52 million tons annually).  All tonnage is subject to a variation of 5%. The price was established based on the prevailing market price for coal at the time the contract was entered into.

The second contract provides for the sale of 130,000 metric tons per month for the first 12 months (1.56 million metric tons annually), increasing to 210,000 metric tons per month for the second and third years (2.52 million metric tons annually).  All tonnage is subject to a variation of 5%. The price was established based on the prevailing market price for coal at the time the contract was entered into.

NewLead intends to source the coal to meet such contracts from the estimated reserves discussed above, but to the extent it is unable to do so, it will be required to seek to source the coal from other suppliers at the prevailing prices.

Management Company
NewLead also entered into an agreement to acquire a local coal mining management company in exchange for compensation, paid in the form $3.0 million in common shares of NewLead and a warrant for $6.4 million in common shares of NewLead. Such acquisition is subject to a number of terms and conditions and there is no assurance it will be consummated. The management company shall be responsible for managing the daily operations of the coal mines and the excavation of the coal from the properties.

About NewLead Holdings Ltd.
NewLead Holdings Ltd. is an international, vertically integrated shipping and commodity company that manages product tankers and dry bulk vessels. NewLead currently controls four vessels, two tankers and two dry bulk vessels. NewLead’s common shares are traded under the symbol “NEWL” on the NASDAQ Global Select Market. To learn more about NewLead Holdings Ltd., please visit the new website at www.newleadholdings.com.

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995
This press release includes assumptions, expectations, projections, intentions and beliefs about future events. These statements, as well as words such as “anticipate,” “estimate,” “project,” “plan,” and “expect,” are intended to be ”forward-looking” statements. We caution that assumptions, expectations, projections, intentions and beliefs about future events may vary from actual results and the differences can be material. Forward-looking statements include, but are not limited to, such matters as the creditworthiness of our counterparties, the reliability of the reserve reports, our ability to extract or acquire coal to fulfil contracts, future operating or financial results; our liquidity position and cash flows, our ability to borrow additional amounts under our revolving credit facility and, if needed, to obtain waivers from our lenders and restructure our debt, and our ability to continue as a going concern; statements about planned, pending or recent vessel disposals and/or acquisitions, business strategy, future dividend payments and expected capital spending or operating expenses, including dry-docking and insurance costs; statements about trends in the product tanker and dry bulk vessel shipping segments, including charter rates and factors affecting supply and demand; expectations regarding the availability of vessel acquisitions; completion of repairs; length of off-hire; availability of charters; and anticipated developments with respect to any pending litigation. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although NewLead believes that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, NewLead cannot assure you that it will achieve or accomplish these expectations, beliefs or projections described in the forward looking statements. Important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include the strength of world economies and currencies, general market conditions, including changes in charter rates and vessel values, failure of a seller to deliver one or more vessels, and other factors discussed in NewLead’s filings with the U.S. Securities and Exchange Commission from time to time. NewLead expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in NewLead’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

Cautionary Note to U.S. Investors
The United States Securities and Exchange Commission limits disclosure for reporting purposes to mineral deposits that a company can economically and legally extract or produce. We use certain terms on this press release, such as “reserves,” “resources,” “geologic resources,” “proven,” or “probable,” which may not be consistent with the reserve definitions established by the SEC. U.S. Investors are cautioned not to assume that any part or all of mineral deposits in these categories will ever be converted into SEC Industry Guide 7 reserves. U.S. investors are urged to consider closely the disclosure in our SEC filings to be filed in the future. You can review and obtain copies of these filings from our website or at http://www.sec.gov/edgar.shtml.

Investor and Media Relations:
Elisa Gerouki
NewLead Holdings Ltd.
Telephone: + 30 213 014 8023
Email: egerouki@newleadholdings.com

Newman Ferrara LLP Announces Investigation of K-Swiss Inc. (KSWS)

Newman Ferrara LLP is investigating potential claims against the board of directors of K-Swiss Inc. (“K-Swiss”) (NasdaqGS: KSWS) concerning the proposed acquisition of K-Swiss by South Korean retail conglomerate E.Land World Ltd. (“E.Land”).

On January 16, 2013, K-Swiss announced that it had entered into a definitive agreement to be acquired by E.Land in an all cash deal valued at approximately $170 million. Under the terms of the agreement, K-Swiss shareholders will receive $4.75 in cash per share of K-Swiss stock owned. However, analysts have set a target price for K-Swiss stock at $5.60 per share.

K-Swiss’ Board of Directors has unanimously approved the proposed deal, which requires the approval of 80% of K-Swiss’ outstanding voting power. However, Steven Nichols, Chief Executive Officer and Chairman of the K-Swiss Board, possesses approximately 69% of that total voting power, which he has pledged to vote in favor of the deal.

Newman Ferrara LLP’s investigation concerns whether K-Swiss’ Board of Directors has breached its fiduciary duties to act in the best interests of K-Swiss shareholders and to take all necessary steps to ensure that K-Swiss shareholders receive the maximum value readily available for their shares of K-Swiss common stock.

Concerned investors are encouraged to contact Newman Ferrara attorney Roy Shimon at (212) 619-5400 or rshimon@nfllp.com to discuss this investigation, their rights, or potential remedies.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.

GlobalWise (GWIV) CEO to Speak at Technology United Executive Conference

COLUMBUS, OH — (Marketwire) — 01/17/13 — GlobalWise Investments, Inc. (OTCBB: GWIV) (OTCQB: GWIV) (www.GlobalWiseInvestments.com) and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today announce a speaking engagement for William J. “BJ” Santiago, CEO of GlobalWise, at the prestigious Technology United Executive Connection Summit.

The Technology United Executive Connection Summit (www.technologyunited.com) is being held in Scottsdale, AZ, from January 22nd – 24th. Other speakers scheduled to deliver a presentation at the event include Konica, SAP and the Technology United Alliance members: Intel, Newfield IT, GreatAmerica Financial Services, LMI, ESP, Green Hills Software, Barrister and GreenPrint.

“We announced being accepted into the invitation-only Technology United organization this past summer and are very pleased to now be presenting at the summit this month,” stated William J. “BJ” Santiago, CEO of GlobalWise. “The Alliance members and the office technology audience in attendance create a fantastic stage for us to grow our channel partnerships and expand the marketing of our cloud-based ECM strategies. This invitation-only conference is geared toward CEOs, Presidents and Senior Vice Presidents, with over 225 confirmed to be attending the 3-day event. I will be speaking in a session titled ‘Channel Changer — Click Charges for Document Management’ to show how the integration of the Intellivue™ software into the copier and multi-function printer eco-system provides a new revenue source for the dealer community. More importantly, this unique approach enables a state-of-the-art ECM solution that finally fits seamlessly within their end-user procurement vessels under similar contracts such as Managed Print Service (MPS) or Document Managed Services (MDS).

“Many in the industry have called our flagship software a ‘channel changer’ because our user-friendly model is similar to the traditional per click charge standard, but introduces a fixed cost model that appeals to a wider customer base. Therefore, the end-user no longer has to worry about being charged more money for each mono (black and white), color or virtual image scan (i.e. Video, Audio, JPEG, PPT, Excel, etc.). Intellivue™ allows the end-user to scan both hard-copy and virtual images, as well as index, search, and retrieve archived data via the cloud, in the same model in which they buy their products today through their dealer. Instead of a per page or per click charge, there is simply a capacity based monthly subscription fee,” concluded Mr. Santiago.

About Technology United

Technology United was established by GlobalWise Channel Partner MWAi’s CEO Mike Stramaglio to form a strategic hub alliance that provides the best-in-class and most aggressive solutions and services that can collectively cover the technology needs within the office space, including IT automation, security and document management services, such as those provided by GlobalWise. Technology United brings together the best partners with the best technology to deliver the best user experience. The solutions created also enable significant cost savings that can improve the bottom line of their clients.

About GlobalWise Investments, Inc.

GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company’s flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape — virtually anything that can be digitized — in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.

For additional information, please visit the Company’s corporate website: www.GlobalWiseInvestments.com

This press release may contain “forward-looking statements.” Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.

GlobalWise Investments, Inc.
Columbus, Ohio
www.GlobalWiseInvestments.com
614-388-8909
Contact@GlobalWiseInvestments.com

Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com